163 related articles for article (PubMed ID: 31135241)
21. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
[TBL] [Abstract][Full Text] [Related]
22. Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.
Dobilas A; Jansåker F; Li X; Sundquist K; Borgfeldt C
BMC Cancer; 2023 Oct; 23(1):951. PubMed ID: 37807065
[TBL] [Abstract][Full Text] [Related]
23. Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark.
Hannibal CG; Baandrup L; Hertzum-Larsen R; Vang R; Kurman RJ; Frederiksen K; Kjaer SK
Int J Cancer; 2023 Apr; 152(7):1370-1377. PubMed ID: 36366853
[TBL] [Abstract][Full Text] [Related]
24. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
Wong KH; Mang OW; Au KH; Law SC
Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
[TBL] [Abstract][Full Text] [Related]
25. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
van Niekerk CC; van Dijck JAAM; Verbeek ALM
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
[TBL] [Abstract][Full Text] [Related]
26. The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.
van Baal JOAM; Van de Vijver KK; Algera MD; van der Aa MA; Sonke GS; van Driel WJ; Kenter GG; Amant FC; Lok CAR
Gynecol Oncol; 2019 Jun; 153(3):562-567. PubMed ID: 30948193
[TBL] [Abstract][Full Text] [Related]
27. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
[TBL] [Abstract][Full Text] [Related]
28. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.
Akeson M; Zetterqvist BM; Dahllöf K; Jakobsen AM; Brännström M; Horvath G
Int J Gynecol Cancer; 2008; 18(3):453-9. PubMed ID: 18476948
[TBL] [Abstract][Full Text] [Related]
29. Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis.
Schuurman MS; Kruitwagen RFPM; Portielje JEA; Roes EM; Lemmens VEPP; van der Aa MA
Gynecol Oncol; 2018 May; 149(2):270-274. PubMed ID: 29514738
[TBL] [Abstract][Full Text] [Related]
30. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
31. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
[TBL] [Abstract][Full Text] [Related]
32. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands.
Legué LM; Bernards N; Gerritse SL; van Oudheusden TR; de Hingh IH; Creemers GM; Ten Tije AJ; Lemmens VE
Acta Oncol; 2016; 55(9-10):1183-1189. PubMed ID: 27170100
[TBL] [Abstract][Full Text] [Related]
33. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
34. Second primary cancers following borderline ovarian tumors.
Sanci M; Gultekin E; Cingillioglu B; Gultekin OE; Ozvural S; Emirdar V; Yildirim Y
Arch Gynecol Obstet; 2011 Jun; 283(6):1391-6. PubMed ID: 20628749
[TBL] [Abstract][Full Text] [Related]
35. Controversies in borderline ovarian tumors.
Seong SJ; Kim DH; Kim MK; Song T
J Gynecol Oncol; 2015 Oct; 26(4):343-9. PubMed ID: 26404125
[TBL] [Abstract][Full Text] [Related]
36. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
[TBL] [Abstract][Full Text] [Related]
37. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
[TBL] [Abstract][Full Text] [Related]
38. Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald.
Koensgen D; Weiss M; Assmann K; Brucker SY; Wallwiener D; Stope MB; Mustea A
Anticancer Res; 2018 Mar; 38(3):1539-1545. PubMed ID: 29491083
[TBL] [Abstract][Full Text] [Related]
39. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.
Hollestein LM; de Vries E; Nijsten T
Eur J Cancer; 2012 Sep; 48(13):2046-53. PubMed ID: 22342554
[TBL] [Abstract][Full Text] [Related]
40. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
